Hess G, Arnold W, Meyer zum Büschenfelde K H
J Med Virol. 1980;5(4):309-16. doi: 10.1002/1096-9071(1980)5:4<309::aid-jmv1890050407>3.0.co;2-l.
Phosphonoformate (PFA) and phosphonoacetate (PAA) were tested for their ability to inhibit the hepatitis-B-virus associated DNA polymerase. The HBV DNA polymerase was inhibited by 100 microM/liter PFA 50% while it was highly resistant to PAA. The inhibition of the Dane particle-associated DNA polymerase by PFA was not competitive to substrates and not affected by changes in the magnesium concentration. PFA was active also after initiation of the DNA polymerase reaction. Competition studies revealed that PFA had a higher affinity to a proposed pyrophosphate binding site than PAA or--alternatively--that both compounds bind to different sites.
膦甲酸(PFA)和膦乙酸(PAA)对其抑制乙型肝炎病毒相关DNA聚合酶的能力进行了测试。100微摩尔/升的PFA可抑制50%的乙肝病毒DNA聚合酶,而它对PAA具有高度抗性。PFA对丹氏颗粒相关DNA聚合酶的抑制作用对底物无竞争性,且不受镁离子浓度变化的影响。在DNA聚合酶反应启动后,PFA仍然具有活性。竞争研究表明,与PAA相比,PFA对假定的焦磷酸结合位点具有更高的亲和力,或者——另一种情况是——这两种化合物结合到不同的位点。